(b)(4).
According to the gore® seamguard® bioabsorbable staple line reinforcement instructions for use (ifu), adverse events that may occur and/or require intervention include, but are not limited to: infection, inflammation, adhesions and hematoma.
|
The following publication which mentions gore® seamguard® bioabsorbable staple line reinforcement was reviewed: a multicenter randomized controlled trial comparing pancreatic leaks after tissuelink versus seamguard after distal pancreatectomy (plats) nct01051856.
Background: pancreatic leak is common after distal pancreatectomy.
This trial sought to compare tissuelink closure of the pancreatic stump to that of seamguard.
Methods: a multicenter, prospective, trial of patients undergoing distal pancreatectomy randomized to either tissuelink or seamguard.
Results: overall, 67 patients were enrolled, 35 tissuelink and 32 seamguard.
Overall, 37 of 67 patients (55%) experienced a leak of any grade, 15 (46.
9%) in the seamguard arm and 22 (62.
9%) in the tissuelink arm (p ¼ 0.
19).
The trial enrolled patients from january 2010 to march 2014, inclusive.
Overall, 58.
2% of patients were female.
Median age for the overall cohort was 57 yrs.
Fifteen patients experienced leaks, while 4 required a percutaneous drain in the seamguard group.
|